Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) in a US$14.6 billion deal, marking the largest acquisition for the sector in over two years. The purchase, which is expected to close later this year pending regulatory and shareholder approvals, will give J&J access…
Biotech is a dynamic industry that is driving scientific advancements and innovation in healthcare. In Canada, the biotech industry…
Gold Mountain Limited (ASX: GMN) (“Gold Mountain” or “the Company” or “GMN”) is excited to announce it has received…
Bitcoin adoption is gaining traction as several US states propose measures to establish strategic reserves. The trend stems from…
International Graphite (IG6:AU) has announced $4m Grant Awarded for Springdale & Collie advancement Download the PDF here. This post…
Cryptocurrencies such as Bitcoin and Ethereum offer an alternative route for building and storing wealth. While directly holding these…
Zinc prices gained more than 16 percent in 2024. While the metal’s value has trended down in the first…
Stock Trend Capital Inc. (CSE: PUMP) (FSE: P0G) (PTC Pink: STOCF) (the ‘Company’ or ‘Stock Trend’) announces that the…
Boab Metals (ASX:BML) is a base and precious metals explorer and developer progressing toward a final investment decision (FID)…